sonnet biotherapeutics stock target price

1 day agoSonnet BioTherapeutics Holdings Inc a clinical-stage company developing targeted immunotherapeutic drugs announced that it received notice from The Nasdaq Stock Market. NASDAQSONN the Company or Sonnet BioTherapeutics a clinical-stage.

Sonnet Biotherapeutics Inc Sonn Message Board Investorshub

3 Wall Street analysts that have issued a 1 year SONN price target the average SONN price target is 200.

. Evolution of the average Target Price on SONNET BIOTHERAPEUTICS. Stock Forecast Open a Brokerage Account NASDAQSONN. Sonnet BioTherapeutics Announces Progress in Two Phase 1 Dose-Escalation Trials of SON-1010 Sep 16 2022 830 AM EDT Sonnet BioTherapeutics Announces 1-for-14 Reverse Stock.

Analyze Sonnet BioTherapeutics target price and analyst consensus to evaluate buy or sell recommendation on Sonnet BioTherapeutics. Sonnet BioTherapeutics has a Price Target of 33. Find the latest Sonnet BioTherapeutics Holdings SONN analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

Sonnet BioTherapeutics Price Targets. Based on the Sonnet Biotherapeutics stock forecast from 1 analyst the average analyst SONN stock price target is USD 200 over the next 12 months. Sonnet Biotherapeutics Holdings Inc.

The forecasts range from a low of 200 to a. The average Sonnet Biotherapeutics Holdings stock price. 3 Insight into Sonnet BioTherapeutics.

Use the tables below to see what analysts covering SONNET BIOTHERAPEUTICS HOLDINGS INC think. Based on short-term price targets offered by two analysts the average price target for Sonnet BioTherapeutics Holdings Inc. Sonnet BioTherapeutics has a 52 week low of 123 and a 52 week high of 1022.

Last 18 months Recommendations Chart SONNET. Target Price consensus revisions. SONN stock quote history news and other vital information to help you with your stock trading and investing.

Sonnet BioTherapeutics stock opened at 163 on Thursday. SONNET BIOTHERAPEUTICS HOLDINGS INC. While ratings are subjective and will change the latest Sonnet BioTherapeutics SONN rating was a maintained with a price target of 200 to 2200.

SONNET BIOTHERAPEUTICS HOLDINGS INC SONN Price Targets From Analysts. April 6 2020. Stock quote stock chart quotes analysis advice financials and news for share SONNET BIOTHERAPEUTICS HOLDINGS INC.

PRINCETON NJ ACCESSWIRE October 4 2022 Sonnet BioTherapeutics Holdings Inc. NASDAQSONN the Company or Sonnet BioTherapeutics a clinical-stage. 2 days agoPRINCETON NJ ACCESSWIRE October 4 2022 Sonnet BioTherapeutics Holdings Inc.

Daré Bioscience has a consensus price target of. 4 Sonnet BioTherapeutics Insider Details. Sonnet BioTherapeutics presently has a consensus price target of 2800 indicating a potential upside of 180476.

What analysts think SONN stock price will be. Find the latest Sonnet BioTherapeutics Holdings Inc.

Sonnet Biotherapeutics Holdings Inc Sonn Stock Price Quote News Stock Analysis